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Abstract
Porous nanocomposite scaffolds of poly(L-lactic acid) (PLLA) containing different quantities of bioactive glass ceramic (BGC) nano-
particles (SiO2:CaO:P2O5 ! 55:40:5 (mol)) were prepared by a thermally induced phase-separation method. Dioxane was used as the sol-
vent for PLLA. Introduction of less than 20 wt.% of BGC nanoparticles did not remarkably affect the porosity of PLLA foam. However,
as the BGC content increased to 30 wt.%, the porosity of the composite was observed to decrease rapidly. The compressive modulus of
the scaffolds increased from 5.5 to 8.0 MPa, while the compressive strength increased from 0.28 to 0.35 MPa as the BGC content
increased from 0 to 30 wt.%. The in vitro bioactivity and biodegradability of nanocomposites were investigated by incubation in simu-
lated body fluid (SBF) and phosphate-buffered saline, respectively. Scanning electron microscopy, energy dispersive X-ray spectroscopy,
Fourier transform infrared spectroscopy and X-ray diffraction were employed to monitor the surface variation of neat PLLA and PLLA/
BGC porous scaffolds during incubation. PLLA/(20 wt.%)BGC composite exhibited the best mineralization property in SBF, while the
PLLA/(10 wt.%)BGC composite showed the highest water absorption ability.
! 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
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1. Introduction
Tissue engineering has been considered as a practical
therapeutic approach towards the regeneration of human
tissue [1]. Biomaterials for application in tissue engineering
could guide cell attachment, cell proliferation and tissue
regeneration when implanted at the desired site in the
patient’s body. Composites of polymers and bioactive
ceramics have attracted increasing attention as promising
biomaterials for bone tissue engineering [2–4]. Three-
dimensional (3D) porous composite scaffolds can induce
the ingrowth of cell to the desired shape and may facilitate
the vascularization of new generated tissue [5,6].
The desirable combination of biocompatibility of biode-
gradable polymers and the bioactivity of bioceramics could
be achieved by preparation of porous polymer/ceramic
composites by different methods [7–11].
Numerous biodegradable polymers have been used in
the preparation of polymer/ceramic composite. These poly-
mer included poly(L-lactic acid) (PLLA) [2,10–18],
poly(caprolactone) [4,19,20], poly(glycolic acid) [21],
poly(glycolide-co-lactide) [22,23], poly(caprolactone-co-
lactide) [24,25] and polysaccharides [3,26–29].
Some ceramics and glasses can directly bond to living
bone without the formation of surrounding fibrous tissue.
In such cases a bone-like apatite layer is deposited
in vivo between the implant and bone [30]. This mineraliza-
tion ability has been defined as bioactivity of biomaterial.
Hydroxyapatite (HA), which constitutes the inorganic frac-
tion of bone, has been considered to be a bioactive material
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due to its osteoconductivity [31]. However, recent investi-
gation has revealed that bioactive glasses (BAGs) or bioac-
tive glass ceramics (BGCs) have a much better performance
in bone tissue engineering than HA [32,33]. BAG has been
used as bone filler material, applied in clinical treatment of
periodontal disease [34], and used to replace damaged mid-
dle ear bone [35]. Porous BAG can facilitate vasculariza-
tion and new bone ingrowth, so has became a potential
useful material for orthopedic applications [36–38]. Mean-
while, the bioactive filler, comprising BAG and BGC par-
ticles, can serve as a reinforcing component to enhance
the stiffness of polymer composites.
Compared with micron-sized bioactive ceramic parti-
cles, nano-sized particles have a large specific surface area
and can form a tighter interface with the polymer matrix
in composites. Introduction of nano-sized BGC particles
into polymeric materials can not only endow polymer
scaffolds with biomineralization capability but also
increase the stiffness of polymer material without greatly
decreasing the mechanical strength [39–41]. It was found
that BAG nanoparticles prepared via a three-step sol–
gel method exhibit bioactive features when compounded
with PLLA [42]. In this study, BGC nanoparticles with
the composition of SiO2:CaO:P2O5 ! 55:40:5 (mol) were
chosen as the bioactive filler to be combined with PLLA
in order to produce a new generation of biodegradable
scaffolds.
2. Materials and methods
2.1. Materials
Tetraethoxysilane (TEOS), calcium nitrate, citric acid
and ammonium dibasic phosphate were obtained from
Sigma. Poly(ethylene glycol) (PEG, Mn 16,000–24,000)
and dioxane were purchased from Fluka. PLLA (Mw
200,000) was obtained from Stratec.
2.2. Preparation of the BGC nanoparticles based on
SiO2–CaO–P2O5
BGC (SiO2:CaO:P2O5 ! 55:40:5 (mol)) nanoparticles
were prepared in accordance with the method described
in our previous publications [42,43]. Briefly, 7.639 g cal-
cium nitrate and 9.84 ml of TEOS were dispersed in a mix-
ture of 120 ml deionized water and 60 ml ethanol. The pH
of the solution was adjusted to 1–2 with citric acid. Once it
had become transparent, this solution was dropped into
1500 ml of deionized water containing 1.078 g of ammo-
nium dibasic phosphate under vigorous stirring. During
this procedure, the pH of the solution was kept at around
11 with continuous additions of ammonia water. After 48 h
of stirring and 24 h of ageing, the precipitate was separated
from the reaction mixture by centrifugation at 10,000 rpm,
and washed three times with deionized water. Then, the
white precipitate was suspended in a 2% (w/v) PEG–water
solution. The precipitate coated with PEG was freeze dried
and calcinated at 700 "C, to obtain the final white BGC
nanoparticles.
2.3. Transmission electron microscopy (TEM) observation
TEM (JEOL JEM-1010) was used to observe the
size and shape of the BGC nanoparticles. The TEM
specimen was prepared by putting one drop of 0.1%
BGC/ethanol suspension onto a TEM grid covered with
carbon film and evaporating the solvent completely at
room temperature.
2.4. Preparation of the PLLA/BGC nanocomposite scaffolds
The PLLA/BGC nanocomposites scaffolds were pre-
pared using a freeze drying method. Briefly, a given
amount of BGC powder was homogeneously suspended
in dioxane using an ultrasonicator and a magnetic stirrer.
PLLA was dissolved in the BGC–dioxane suspension to
produce an homogeneous 5% (w/v) PLLA–dioxane solu-
tion. The mixture was stirred overnight to obtain a polymer
solution. After freeze drying at "80 "C for 1 week, porous
PLLA/BGC composite scaffolds were obtained.
2.5. Porosity of composite
The total porosity of the composite with different BGC
contentswas calculated on the basis of their apparent density
q and bulk density q0 according to the following equation:
porosity % = (1 " q/q0) # 100. The q and q0 were measured
from porous scaffold and bulk samples, respectively, on the
basis of their dimensions and weights. Triplicate measure-
ments were carried out to obtain their mean values.
2.6. Mechanical properties
An Instron test machine (1121 Instron Instruments,
UK) was employed to evaluate the compressive properties
of the porous scaffolds at room temperature. Cubic speci-
mens 10 # 10 # 10 mm were placed between two solid plat-
ens and compressed at a rate of 1 mm min"1. The degree of
statistical significance between composites and control
PLLA scaffolds was estimated by t-test, with P < 0.05
being taken as statistically significant. Five samples of
each formulation were analyzed to determine statistical
significance.
2.7. In vitro bioactivity study
The in vitro bioactivity test was carried out by soaking
10 # 10 # 2 mm porous scaffolds in 10 ml of simulated
body fluid (SBF; Na+ 142.0, K+ 5.0, Ca2+ 2.5, Mg2+ 1.5,
Cl" 148.0, HCO3" 4.2, HPO2"4 1.0, SO
2"
4 0.5 mM) in conical
flasks, and placing the samples in an oven at 37 "C for 1, 3,
7, 14 and 21 days. After the different soaking periods, the
scaffolds were taken out from SBF, rinsed with deionized
water and freeze dried. The formation of apatite on the
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porous PLLA and PLLA/BGC composite were character-
ized by scanning electron microscopy (SEM), energy disper-
sive X-ray spectroscopy (EDX), Fourier transform infrared
spectroscopy (FTIR) and X-ray diffraction (XRD).
2.8. SEM and EDX
SEM images of the porous morphologies and apatite
formation on the scaffolds were obtained at 15 kV on a
Leica Cambridge S-360 microscope equipped with a LINK
eXLII X-ray energy dispersion spectrometer. For SEM
observation, samples were coated with gold using a sputter
coater (JFC 1100, JEOL). For EDX analysis, all samples
were coated with carbon to avoid the overlap of the peaks
of gold and phosphorous [44,45].
2.9. FTIR spectroscopic analysis
A Bio-Rad Win-IR spectrometer was employed for
FTIR spectroscopic analysis. The powders scratched from
the surface of a PLLA/(20 wt.%)BGC scaffold soaked in
SBF for 21 days were dried at 150 "C for 2 h under vacuum
to remove adsorbed water, mixed with KBr powder and
pressed into a disk suitable for FTIR measurement. The
FTIR spectra were recorded from 400 to 4000 cm"1.
2.10. XRD
XRD analysis were performed on an X-ray diffractome-
ter (Philips PW 1710, Netherlands) with Cu Ka radiation
(k = 0.154 nm). Voltage and current were selected as
40 kV and 50 mA, respectively. Data were collected from
2h = 10" to 60" with a step size of 0.02".
2.11. In vitro degradation study
In vitro degradation studies were carried out via the
same method described in previous work [42]. Briefly, sam-
ples with dimensions of 10 # 10 # 2 mm were sterilized by
UV exposure under a laminar flow hood for 10 min on
each side and placed in sterile Falcon tubes. For each time
point, three samples of each composition were immersed in
10 ml phosphate-buffered saline (PBS) and incubated under
slow tangential agitation at 37 "C. The pH of the medium
was recorded at each time point. After any given time
point, samples of each composition were removed from
the PBS and weighed (Ww) after wiping the surface with fil-
ter paper. Each sample was repeatedly rinsed with deion-
ized water to remove the soluble inorganic salt, and
weighed (Wd) after being completely dried in an oven.
Water absorption (WA%) and weight loss (WL%) were cal-
culated according to the following equations, respectively:
W A% ¼ ½ðW w–W iÞ=W i( # 100% ð1Þ
W L% ¼ ½ðW d–W iÞ=W i( # 100% ð2Þ
where Wi is the initial weight of each sample.
3. Results and discussion
3.1. Porous PLLA/BGC nanocomposites
A TEM image of BGC nanoparticles dispersed in etha-
nol is shown in Fig. 1. It can be seen that the BGC particles
are homogeneous nanospheres, )20–40 nm in diameter. It
can also be seen that BGC nanoparticles tend to aggregate
to form larger BGC clusters due to the high specific surface
area and surface energy of the nanoparticles.
SEM images of neat PLLA foam and PLLA/BGC com-
posites with different BGC contents are presented in Fig. 2.
The representative morphology of a neat PLLA foam
(Fig. 2A and E) shows a typical microstructure of
polymeric foam prepared by thermally induced phase-sep-
aration [2,46]. The influence of content on the microstruc-
ture of PLLA/BGC composites was investigated by
varying the BGC content while maintaining the PLLA con-
centration constant in the dioxane solutions. At 10 wt.%
(Fig. 2B) and 20 wt.% (Fig. 2C) BGC content, PLLA/
BGC composites show a continuous microstructure of
interconnected pores 20–400 lm in diameter, which is very
similar to the microporous structure of pure PLLA foam
(Fig. 2A). This result suggests that, up to 20 wt.% content,
BGC nanoparticles do not influence the mechanism of pore
formation via crystallization and phase-separation of diox-
ane. In the high-magnification image of PLLA/
(10 wt.%)BGC and PLLA/(20 wt.%)BGC (Fig. 2F and
G), some micro-sized BGC aggregates could be seen on
the wall of pores. If the filler loading increased to
30 wt.%, the morphology of composite appeared to be very
different from the other two scaffolds (Fig. 2D and H). In
this case, the pore size ranges from 10 to 150 lm. This
reduction in pore size could be attributed to the decrease
in solvent volume relative to the total weight of PLLA
and BGC nanoparticles during the preparation of the
composites. Moreover, high filler contents might change
Fig. 1. TEM morphology of BGC nanoparticles. Bar is 200 nm.
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the crystallization and phase-separation behavior of diox-
ane solvent in the PLLA–BGC–dioxane system. The
BGC nanoparticles that were densely dispersed in the
PLLA–dioxane solution could provide a large number of
nucleation spots and disturb the growth of the dioxane
crystals at low temperature.
Both the density and porosity of the PLLA/BGC nano-
composites are listed in Table 1. The apparent density of
composite gradually increases with increasing BGC content
in the scaffolds. The introduction of 10 and 20 wt.% BGC
nanoparticles in the PLLA matrix does not noticeably
change the porosity of the PLLA foam. However, when
the filler content increased to 30 wt.%, the porosity of the
composites apparently decreased greatly. This finding is
in agreement with the result of SEM observation.
The mechanical properties of the PLLA/BGC nanocom-
posites were evaluated by compressive measurements. The
relationship between compressive properties and BGC
Fig. 2. SEM morphology for the porous PLLA/BGC scaffolds with different BGC contents: at low-magnification: (A) 0 wt.%, (B) 10 wt.%, (C) 20 wt.%
and (D) 30 wt.%; at high-magnification (E) 0 wt.%, (F) 10 wt.%, (G) 20 wt.% and (H) 30 wt.%.
Table 1
Apparent density and porosity of the PLLA/BGC nanocomposite
scaffolds
BGC content in
composite
(wt.%)
Apparent
density (q,
g cm"3)
Bulk density of PLLA/
BGC composite (q0,
g cm"3)
Porosity
(%)
0 0.09 ± 0.01 1.08 ± 0.03 91.7
10 0.10 ± 0.02 1.25 ± 0.02 92.0
20 0.12 ± 0.03 1.33 ± 0.03 91.0
30 0.17 ± 0.02 1.46 ± 0.06 88.4
The data were representative of three samples and expressed as
mean ± SD (n = 3).
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content is summarized in Fig. 3. The compressive strength
of composite increased from 0.27 to 0.35 MPa while the
compressive modulus increased from 5.5 to 8 MPa as the
BGC content increased from 0 to 30 wt.%. This provides
evidence that addition of BGC nanoparticles can effectively
improve the mechanical properties of the PLLA porous
scaffold. The enhancement of the mechanical performance
due to the introduction of inorganic nanoparticles in com-
posites has been intensively discussed in previous works
[23,47].
3.2. In vitro bioactivity tests
In order to analyze the osteoconductive character of the
materials, and their potential for use in bone tissue engi-
neering, bioactivity tests in SBF were performed on the
PLLA/BGC nanocomposite scaffolds. Fig. 4 shows the
morphology of porous PLLA and PLLA/BGC scaffolds
after soaking in SBF for different periods. The composites
with different BGC contents exhibit different bioactivities
in SBF. For plain PLLA foam, some publications have
reported that porous PLLA scaffolds could induce the
development of bone-like HA after soaking in SBF
[12,48,49]. However, in this study, no apatite was formed
Fig. 3. Dependency of compressive strength and compressive modulus on
the filler content in the porous nanocomposites. *P < 0.05: values were
significantly different from the control PLLA group.
Fig. 4. Morphology of the porous PLLA/BGC composites with different contents of BGC particles after immersion in SBF for different periods, observed
by SEM: (A) 0 wt.%, (B) 10 wt.%, (C) 20 wt.% and (D) 30 wt.%. The subscripts indicate the incubation time in SBF (days). The images inserted in the C
series are the high-magnification pictures of apatite clusters formed on the surface of PLLA/(20 wt.%)BGC composites after different soaking times.
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on the surface of neat PLLA material after soaking in
1 # SBF as shown in Fig. 4A series. The result seems to
indicate that less apatite tends to precipitate on the surface
and in the interior of the PLLA scaffold. In this context it
was suggested that the surface features of PLLA/Bioglass#
particles could be changed, for example, by grafting a
thermo-responsive polymer [50]; this produced smart mate-
rials that could induce calcification, or not, depending on
the environmental temperature. For the 10 wt.% BGC con-
tent formulation, no apparent changes occurred on the sur-
face of the composite scaffolds after soaking in SBF for 7
days (Fig. 4B7). After 21 days of incubation, some cauli-
flower-like apatite clusters were formed on the surface of
composite. For 20 wt.% BGC content, the biomineraliza-
tion ability of the composite was greatly enhanced. After
1 day of incubation, the apatite clusters covered almost
the entire surface of the scaffolds (Fig. 4C1). The profile
of particles was clear, and elongated with increasing
immersion time as shown in the high-magnification mor-
phology of Fig. 4C series. This variation in particle shape
was generally attributed to the tendency of HA to grow
along the c-axis direction [51]. For PLLA/(30 wt.%)BGC
composite, after 1 day of incubation, nucleation and
growth of apatite occurred on the exposed surface of the
scaffold. However, the apatite clusters did not cover the
entire surface of the composite. The results suggest that
formation of bone-like apatite on PLLA/(30 wt.%)BGC
composite is delayed as compared with PLLA/
(20 wt.%)BGC composite. This could be attributed to the
overloading of BGC in the composite. The formulation
with higher BGC content could result in more exposed
BGC surface, but excessive exposed surface could decrease
the development rate of apatite in SBF [12,52].
The results obtained by SEM were confirmed by EDX
analysis as shown in Fig. 5. No obvious changes can be
detected in the EDX curves for neat PLLA foam before
and after soaking in SBF as shown in Fig. 4A1–A21.
EDX curves for the composites with different BGC con-
tents show the presence of silicon (Si), calcium (Ca) and
phosphorus (P), and their relative quantity on the surface
of the materials (Fig. 5B–D). As shown in Fig. 5B and
D, the ratio of Si, Ca and P gradually changes with incuba-
tion time for PLLA/(10 wt.%)BGC and PLLA/
(30 wt.%)BGC composite. However, a significant variation
in the intensity of Si, P and Ca can be observed for the
EDX data of the PLLA/(20 wt.%)BGC scaffold (Fig. 5C).
In this case, it can be seen that after soaking in SBF, the
concentrations of Ca and P significantly increase, accom-
panied by a decrease in the concentration of Si, which
strengthens the indication of an extended development of
apatite. From the result of EDX analysis, it can be con-
cluded that the mineralization ability of the PLLA/
(20 wt.%)BGC composite was superior to the other two
formulations, which is in agreement with the SEM
observations.
Fig. 6 shows XRD patterns of PLLA/(20 wt.%)BGC
nanocomposites after soaking in SBF for different periods.
After 1 day of incubation, the typical crystalline diffraction
pattern of apatite can be observed with an evident peak at
2h = 26" and 2h = 32", which further intensified with
increasing incubation time.
In addition, it could be seen that the PLLA matrix is in
the amorphous state in the porous composites prepared by
thermally induced phase-separation method. When the
temperature was lowered to the upper critical solution tem-
perature (UCST) of PLLA–dioxane solution, the homoge-
neous PLLA–dioxane solution separates into bicontinuous
phases of PLLA and dioxane solvent to form an interpen-
etrating network structure. In this stage, the PLLA phase
still contains a small quantity of dioxane solvent, whereas
the dioxane phase also includes some PLLA solute. As
the temperature is lowered further down to "80 "C, both
of these phases would be deep frozen. Hence, during the
sublimation process of dioxane at "80 "C, PLLA molecu-
lar chains were frozen in the solvent crystal lattice, prevent-
ing conformational mobility towards crystallization.
The FTIR spectrum of HA formed on the surface of
PLLA/BGC composite is illustrated in Fig. 7a. The sample
powder was scratched and collected from the surface of the
PLLA/(20 wt.%)BGC composite after soaking in SBF for
21 days. The spectrum of the particle is very similar to that
of HA synthesized by coprecipitation method without cal-
cination. Double peaks at 1450 and 1415 cm"1 indicate
that the macroparticles formed on the surface of the com-
posite correspond to carbonated apatite. The peak at 1760
(Fig. 7a) can be attributed to the vibration band of the car-
bonyl group of PLLA, which was scratched from the sur-
face of PLLA/BGC composite together with the HA
particles during the preparation of the FTIR sample.
3.3. In vitro degradation
In order to study the effect of BGC content on the degra-
dability of the PLLA/BGC nanocomposite scaffolds,
in vitro degradability tests were carried out in PBS (pH
7.4) at 37 "C. The degradation process was monitored by
water uptake, weight loss and pH variation in the PBS med-
ium. Fig. 8 shows the water uptake of the PLLA/BGC com-
posites with different BGC content. It can be observed that
after 1 day of immersion, compared with PLLA porous
scaffold, the water content of all the PLLA/BGC compos-
ites increased with the introduction of BGC nanoparticles,
which have a hydrophilic character. This result is consistent
with our previous findings [42]. A mass increase of 600% is
observed for pure PLLA foam, while for PLLA/BGC com-
posites, this increase ranges from 650% to 800%. PLLA/
(10 wt.%)BGC composite exhibits the highest water absorp-
tion rate throughout the whole incubation period. The
water uptake ability of the nanocomposite gradually
decreases with further increase of filler loading due to the
decrease in porosity at high filler contents. This result agrees
with the results of the porosity analysis (Table 1).
The weight loss for the different porous PLLA/BGC
scaffolds is shown in Fig. 9. The weight loss for the
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PLLA/BGC composites is slightly higher than for the plain
PLLA foam, indicating a preferential dissolution of the
inorganic component. After 30 days of incubation the
PLLA/(30 wt.%)BGC composites lost about 8% of their
initial mass, which is slightly higher than loss in the other
two composites.
pH variation of PBS media with different incubation
times is presented in Fig. 10. Acidic groups resulting from
the degradation of PLLA could decrease the pH value of
medium, while the dissolution of the BGC nanoparticles
could alkalize the medium. Therefore, the pH of the med-
ium should depend on both the degradation rate of PLLA
Fig. 5. EDX curves for porous PLLA/BGC composites with different contents of BGC particles after immersing in SBF for different periods: (A) 0 wt.%,
(B) 10 wt.%, (C) 20 wt.% and (D) 30 wt.%. The subscripts indicate the incubation time in SBF (days).
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matrix and the dissolution profile of the BGC nanoparti-
cles. As shown in Fig. 10, a slight decrease in pH occurs
at the initial incubation stage for the PLLA foam. After
3 days of incubation, the pH value of the medium of neat
PLLA foam reaches a plateau value at around 7.3. The pH
evolution of the PLLA/BGC composites with 10, 20, and
30 wt.% BGC content exhibits a different trend, slightly
increasing in the first day of incubation and then decreasing
gradually to around 7.2, 7.1 and 6.8 after 4 weeks of incu-
bation, respectively. Several publications [2,53–55] have
reported that bioactive ceramic filler could delay the degra-
dation of the composite scaffolds by the neutralizing effect
of the alkaline ions released from the bioactive ceramic
particle in culturing medium. However, in this study, dur-
ing 4 weeks of incubation, it was found that overloading
BGC nanoparticles could accelerate the degradation of
PLLA/BGC composites. Hydrophilic BGC nanoparticles
with a large specific area could facilitate the infiltration
of water inside the composite structure, which might result
in an enhancement of degradation of the PLLA matrix in
Fig. 6. XRD patterns of the PLLA/(20 wt.%)BGC composite after
soaking in SBF for different periods (days).
Fig. 7. FTIR spectra for: (a) the powder scratched from the surface of the
PLLA/(20 wt.%)BGC scaffold after soaking in SBF for 21 days and (b)
HA synthesized by coprecipitation method with Ca(OH)2 and H3PO4 at
60 "C, presented as a reference.
Fig. 8. Water uptake vs. incubation time in PBS for porous PLLA/BGC
composites with different BGC contents: (a) 0 wt.%, (b) 10 wt.%, (c)
20 wt.% and (d) 30 wt.%.
Fig. 9. Weight loss vs. incubation time in PBS for porous PLLA/BGC
composites with different BGC contents: (a) 0 wt.%, (b) 10 wt.%, (c)
20 wt.% and (d) 30 wt.%.
Fig. 10. Change in pH in PBS medium vs. incubation time for porous
PLLA/BGC composites with different BGC contents: (a) 0 wt.%, (b)
10 wt.%, (c) 20 wt.% and (d) 30 wt.%.
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both the surface and the interior of the composite, releasing
more acidic degradation products into the medium [25,55].
4. Conclusion
PLLA/BGC nanocomposite scaffolds with different
BGC contents were obtained via a thermally induced
phase-separation method, in which dioxane was used as
the solvent for PLLA. Introduction of 10 and 20 wt.%
BGC nanoparticles in PLLA did not remarkably alter the
morphology and porosity of the scaffolds. The apparent
density of the materials increased with increasing BGC
content. The porosity of the scaffolds containing 30 wt.%
BGC decreased remarkably as compared with both
PLLA/(10 wt.%)BGC and PLLA/(20 wt.%)BGC formula-
tions. Mechanical properties could be improved by adding
the developed BGC nanoparticles in the PLLA matrix. In
vitro mineralization tests showed that of the three compos-
ites and neat PLLA foam, the PLLA/(20 wt.%)BGC com-
posite exhibits the best bioactivity features. Biodegradation
results indicated that the inclusion of BGC nanoparticles
could increase the water uptake of PLLA scaffolds, espe-
cially at a lower BGC loading, and greatly affect the degra-
dation rate of the PLLA matrix.
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